Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress
Rui S. RodriguesiD, João B. MoreiraiD, Joana M. MateusiD, Andreia Pereira BarateiroiD, Sara L. PauloiD, Sandra Henriques VaziD, Diogo M. LourençoiD, Filipa F. RibeiroiD, Rita B. SoaresiD, Eduardo Loureiro‐CamposiD, Pascal BielefeldiD, Ana Maria SebastiãoiD, Adelaide Maria Afonso FernandesiD, Luísa PintoiD, Carlos Patricio FitzsimonsiD, Sara XapelliiD
Abstract
Chronic stress is a major risk factor of neuropsychiatric conditions such as depression. Adult hippocampal neurogenesis (AHN) has emerged as a promising target to counteract stress-related disorders given the ability of newborn neurons to facilitate endogenous plasticity. Recent data sheds light on the interaction between cannabinoids and neurotrophic factors underlying the regulation of AHN, with important effects upon cognitive plasticity and emotional flexibility. Since physical exercise (PE) is known to enhance neurotrophin levels, we hypothesized that PE could engage with cannabinoids to influence AHN and that this would result in beneficial effects under stressful conditions. We therefore investigated the actions of modulating cannabinoid type 2 receptors (CB2R), which are devoid of psychotropic effects, in combination with PE in chronically stressed animals. We found that CB2R inhibition, but not CB2R activation, in combination with PE significantly ameliorated stress-evoked emotional changes and cognitive deficits. Importantly, this combined strategy critically shaped stress-induced changes in AHN dynamics, leading to a significant increase in the rates of cell proliferation and differentiation of newborn neurons, and an overall reduction in neuroinflammation. Together, these results show that CB2Rs are crucial regulators of the beneficial effects of PE in countering the effects of chronic stress. Our work emphasizes the importance of understanding the mechanisms behind the actions of cannabinoids and PE and provides a framework for future therapeutic strategies to treat stress-related disorders that capitalize on lifestyle interventions complemented with endocannabinoid pharmacomodulation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 3.39
- Field percentile
- top 8%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exercise Leverages a Post-Stress Therapeutic Window in Hypothalamic CRH Neurons to Enable Recovery from Threat Sensitization
Mijail Rojas‐Carvajal, Tamás Füzesi, … Jaideep Singh Bains·bioRxiv·Jan 8, 2026
- Disruption of Tonic Endocannabinoid Signaling Triggers the Generation of a Stress Response
Gavin N. Petrie, Georgia Balsevich, … Matthew N. Hill·bioRxiv·Sep 27, 2022
- Impaired cognitive performance under psycho-social stress in cannabis-dependent males is mediated by attenuated precuneus activity
Weihua Zhao, Kaeli Zimmermann, … Benjamin Becker·bioRxiv·Feb 19, 2019
- Endocannabinoid and psychological responses to acute resistance exercise in trained and untrained adults
Z. Sirotiak, B. T. Gallagher, … A. G. Brellenthin·bioRxiv·Sep 8, 2023
- Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
D. Cabanero, A. Ramirez-Lopez, … R. Maldonado·bioRxiv·May 19, 2020
- Key contribution of prefrontal inhibition to passive coping behaviour: chronic stress and fast-acting antidepressant
Tsz Hei Fong, Tianxiang Li, … Qiang Zhou·NeuropsychopharmacologyPeer-reviewed·Aug 16, 2025